A radiology group in North Carolina is suing its insurance broker, alleging the company’s cyber policies were allowed to lapse just before a ransomware attack—and that it only found out when it tried to make a claim. Raleigh Radiology Associates filed a lawsuit in federal court on April 28, claiming that the broker, the Risk ...

Shares of Prometheus Biosciences (ticker: RXDX) rose nearly 70% in premarket trading to $193.57 after Merck (MRK) agreed to buy the clinical-stage biotechnology company for $200 a share or about $10.8 billion. The deal for Prometheus, which focuses on treatments for autoimmune disease, is expected to close in the third quarter. Merck fell 0.2%. Meanwhile, ...

About the author: Allan Sloan is an independent business journalist and seven-time winner of the Loeb Award, business journalism’s highest honor. A great medical breakthrough doesn’t necessarily make for a great medical investment. Nestlé, which is best known for products like chocolate chips, Purina petfood, and Nescafe coffee but also has a sizable health-sciences business, ...

Watching the gyrations in the market this past month makes anyone dizzy. And nervous. After years of long-term rising stock-market values SPX, +1.18% GDOW, +0.90%, we are faced with rising inflation and rising interest rates TMUBMUSD10Y, 4.028% —a financial situation not seen in 40 years. No matter how much you worry about your investments, you ...